• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Fierce Pharma Marketing tees up trends for 2021—and big news, they're not all...

cafead

Administrator
Staff member
  • cafead   Dec 21, 2020 at 11:32: AM
via After 2020, can we ever count on the past to predict trends again? Think about it. Just one year ago, we forecast the rising tide of politics and drug pricing, podcasts as an emerging marketing channel and targeting through artificial intelligence.

While some of those things did happen, did anyone notice? The entire year was overshadowed by the pandemic—as middle sister Jan from "The Brady Bunch" might have said, 2020 was just “COVID, COVID, COVID.”

article source